Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers.
The objective of the present work was to study the preparation, optimization and characteristics of Huperzine A (Hup A), an effective Traditional Chinese Medicine treatment of Alzheimer's disease (AD), loaded nanostructured lipid carriers (NLC). NLC were successfully prepared by a modified method of melt ultrasonication followed by high pressure homogenization using Cetyl Palmitate (CP) as the solid lipid, Miglyol((R))812 as the liquid lipid, Soybean phosphatidylcholine (Spc) and Solutol HS15 as the emulsifiers. The best formulation was optimized with a three-factor, three-level Box-Behnken design. Independent variables studied were the amount of the mixed lipid, the amount of the emulsifier mixture and lipid/drug ratio in the formulation. The dependent variables were the particle size, entrapment efficiency (EE) and drug loading (DL). Properties of NLC such as the morphology, particle size, zeta potential, EE, DL and drug release behavior were investigated, respectively. As a result, the designed nanoparticles showed nearly spherical particles with a mean particle size of 120 nm and -22.93 + or - 0.91 mV. The EE (%) and DL (%) could reach up to 89.18 + or - 0.28% and 1.46 + or - 0.05%, respectively. Differential scanning calorimetry (DSC) of Hup A loaded NLC indicated no tendency of recrystallisation. In vitro release studies showed a burst release at the initial stage and followed by a prolonged release of Hup A from NLC up to 96 h. The results suggest that the presented Hup A loaded NLC system is a potential delivery system for improving drug loading capacity and controlled drug release.
Yang
Chun-Rong
CR
School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning 110016, P. R. China. yangchunrong98@yahoo.com.cn
Zhao
Xiu-Li
XL
Hu
Hai-Yang
HY
Li
Ke-Xin
KX
Sun
Xin
X
Li
Lei
L
Chen
Da-Wei
DW
D000470:Alkaloids; D002152:Calorimetry, Differential Scanning; D004337:Drug Carriers / Q000138:chemical synthesis / Q000737:chemistry*; D008055:Lipids / Q000138:chemical synthesis / Q000737:chemistry*; D046529:Microscopy, Electron, Transmission; D049329:Nanostructures / Q000737:chemistry*; D018696:Neuroprotective Agents / Q000138:chemical synthesis / Q000737:chemistry*; D010316:Particle Size; D012717:Sesquiterpenes / Q000138:chemical synthesis / Q000737:chemistry*
D000470:Alkaloids; D004337:Drug Carriers; D008055:Lipids; D018696:Neuroprotective Agents; D012717:Sesquiterpenes; C050426:huperzine A